| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,984 |
9,466 |
$831K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,257 |
11,437 |
$727K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
2,831 |
2,819 |
$269K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
2,475 |
2,466 |
$214K |
| 99215 |
Prolong outpt/office vis |
1,245 |
1,223 |
$132K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,202 |
2,133 |
$83K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,482 |
7,076 |
$77K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,939 |
1,798 |
$58K |
| 36415 |
Collection of venous blood by venipuncture |
12,640 |
11,993 |
$35K |
| 90688 |
|
1,282 |
1,280 |
$24K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,161 |
1,079 |
$21K |
| G0008 |
Administration of influenza virus vaccine |
1,764 |
1,761 |
$17K |
| 71046 |
Radiologic examination, chest; 2 views |
1,007 |
987 |
$17K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
1,877 |
1,843 |
$17K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,348 |
1,315 |
$16K |
| 93000 |
|
1,364 |
1,341 |
$12K |
| 82962 |
|
4,835 |
4,633 |
$11K |
| 81002 |
|
3,943 |
3,794 |
$10K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,688 |
1,646 |
$9K |
| 99000 |
|
1,425 |
1,312 |
$9K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
244 |
238 |
$8K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
108 |
106 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
377 |
366 |
$7K |
| 99385 |
|
67 |
67 |
$7K |
| 81025 |
|
840 |
824 |
$6K |
| 0011A |
|
219 |
219 |
$5K |
| 99490 |
Ccm add 20min |
272 |
272 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
42 |
42 |
$5K |
| 0012A |
|
183 |
183 |
$5K |
| 90658 |
|
325 |
323 |
$5K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
191 |
189 |
$4K |
| 0064A |
|
139 |
139 |
$3K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,308 |
2,215 |
$3K |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
619 |
590 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,449 |
3,293 |
$3K |
| 80061 |
Lipid panel |
177 |
174 |
$2K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
38 |
37 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
29 |
29 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
188 |
186 |
$2K |
| 73560 |
|
77 |
63 |
$1K |
| 99406 |
|
191 |
187 |
$1K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
148 |
146 |
$1K |
| 91322 |
|
12 |
12 |
$1K |
| 83735 |
|
169 |
166 |
$1K |
| 90686 |
|
52 |
52 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
100 |
100 |
$861.41 |
| 72100 |
|
42 |
42 |
$837.54 |
| 76770 |
|
14 |
13 |
$812.70 |
| 90480 |
|
27 |
27 |
$683.84 |
| 83014 |
|
200 |
200 |
$642.08 |
| 0004A |
|
31 |
31 |
$613.56 |
| 0001A |
|
16 |
16 |
$542.28 |
| 0003A |
|
14 |
14 |
$534.20 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
535 |
525 |
$521.28 |
| 0013A |
|
13 |
13 |
$462.80 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
265 |
255 |
$434.82 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
44 |
39 |
$417.25 |
| 84460 |
|
68 |
68 |
$372.47 |
| 87807 |
|
43 |
40 |
$269.63 |
| 86580 |
|
44 |
43 |
$228.33 |
| 90653 |
|
13 |
13 |
$173.49 |
| 99442 |
|
12 |
12 |
$123.60 |
| Q2035 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) |
14 |
14 |
$3.65 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
14 |
14 |
$0.26 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
5,868 |
5,238 |
$0.00 |
| 3079F |
|
9,174 |
8,514 |
$0.00 |
| 3080F |
|
5,127 |
4,773 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
2,961 |
2,951 |
$0.00 |
| G8432 |
Depression screening not documented, reason not given |
4,447 |
4,002 |
$0.00 |
| 3075F |
|
3,887 |
3,679 |
$0.00 |
| 3044F |
|
318 |
316 |
$0.00 |
| 3074F |
|
16,678 |
14,912 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
22,423 |
19,738 |
$0.00 |
| 3078F |
|
9,978 |
9,081 |
$0.00 |
| 3077F |
|
3,583 |
3,348 |
$0.00 |
| G8511 |
Screening for depression documented as positive, follow-up plan not documented, reason not given |
301 |
300 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
45 |
45 |
$0.00 |